SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Cutera, Inc. (NASDAQ: CUTR) common stock between February 17, 2021 and May 9, 2023. Cutera is a medical aesthetic device company that provides equipment for beauty treatments.
For more information, submit a form, email Aaron Dumas, Jr., or give us a call (800) 350-6003.
What is this Case About: Cutera, Inc. (CUTR) Misled Investors Regarding its Internal Controls Over Financial Reporting
According to the complaint, throughout the class period, defendants repeatedly assured investors that the Company would deliver sustainable revenue growth in the wake of the COVID-19 pandemic while concealing that the Company maintained inadequate internal control over financial reporting and significant conflicts among certain members of the Company’s senior leadership and board of directors (the “Board”).
Beginning on January 9, 2023, investors began to learn the truth. On that day, the Company announced its failure to meet revenue guidance for 2022. On February 28, 2023, Cutera disclosed its inability to timely file its annual financial report with the SEC and that it had identified material weaknesses in its internal control over financial reporting. On March 16, 2023, Cutera announced it would not meet the extended deadline to file its annual report. Then, on March 24, 2023, Cutera disclosed its non-compliance with Nasdaq Listing Rule 5250(c)(1). Beginning on April 7, 2023, the Company disclosed conflicts with Board members. Finally, on May 9, 2023, Cutera revealed disappointing financial results for the first quarter 2023 “due to execution challenges in the business.” Each disclosure resulted in a decline in Cutera’s stock price, which ultimately closed at $14.14 per share on May 11, 2023.
What Now: Similarly situated shareholders may be eligible to participate in the class action against Cutera, Inc. Shareholders who want to act as lead plaintiff for the class must file their papers by July 24, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
About Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders.
To be notified if a class action against Cutera, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.
Attorney Advertising. Past results do not guarantee a similar outcome.
| Contact: Aaron Dumas, Jr. Robbins LLP 5060 Shoreham Pl., Ste. 300 San Diego, CA 92122 adumas@robbinsllp.com (800) 350-6003 www.robbinsllp.com | https://www.facebook.com/RobbinsLLP/ https://www.linkedin.com/company/robbins-llp/ |
- APLS DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 2 Deadline in Securities Class Action – APLS - September 30, 2023
- ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation – BCLI - September 30, 2023
- Food Additives Market Size Will Attain USD 170.49 Billion by 2030 Growing at 6.5% CAGR – Exclusive Report by Facts and Factors - September 30, 2023
